Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

SANA

Sana Biotechnology, Inc.

CIK 0001770121 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$3.91
↑ 0.17 (4.55%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$1.17B
P/E Ratio
-5.53
EPS
-0.96
Dividend Yield
Not covered
52W Position
33%
Beta
2.34

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
7.57
P/S
Not covered
EV/Revenue
Not covered
ROE
-137.0%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 33%
$2.61$6.55

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$244.17M
Total Assets
$416.89M
Free Cash Flow
-$144.77M

Recent news